Title | Catecholamine Research [electronic resource] : From Molecular Insights to Clinical Medicine / edited by Toshiharu Nagatsu, Toshitaka Nabeshima, Richard McCarty, David S. Goldstein |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 2002 |
Connect to | http://dx.doi.org/10.1007/978-1-4757-3538-3 |
Descript | XXIV, 558 p. online resource |
In Memorium -- Dr. Sidney Udenfriend Memorial Lecture -- Catecholamine Uptake, Storage, and Release -- Regulation of Catecholamine Biosynthetic Enzymes -- The Dopaminergic System -- Developmental Neurobiology of Catecholaminergic Systems -- Physiological Effects of Catecholamines -- Methodological Advances -- Catecholamines Stress and Behavior -- Catecholamines and Drugs of Abuse -- Involvement of Catecholamines in Clinical Medicine -- 99. Dopamine Receptors in Schizophrenia -- 100. The Dopamine Hypothesis of Schizophrenia: New Aspects -- 101. Molecular Genetic Analysis of Plasma Dopamine ?-Hydroxylase in Depression: New Implications for An Old Biomarker -- 102. Dopaminergic Hyperactivity in Striatum in Schizophrenia: A Failure of Cortical Glutamatergic Control? -- 103. Tetrahydrobiopterin Differentially Regulates the Biosynthesis of Catecholamines and Serotonin: Implication in Neuropsychiatric Disorders -- 104. Lithium and Signal Transduction -- 105. Platelet Monoamine Oxidase, Transcription Factor AP-2 and PersonalityโA Functional Triangle? -- 106. Cardiac Sympathetic Denervation in Parkinsonโs Disease -- 107. Dopaminergic Impairment Is Related to Cortical Dysfunction in Parkinsonโs Disease: A PET Study -- 108. Aliphatic Propargylamines as Treatments for Neurodegenerative Diseases: Catecholamine ResearchโFrom Molecular insights to Clinical Medicine -- 109. ร-Carbolines and N-Methylation Underlying Parkinsonโs Disease -- 110. Neuroprotective Actions of Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate in Models of Parkinsonโs Disease: Gene Targets -- 111. Dopamine Transporter and Parkinsonโs Disease -- 112. L-Dopa Responsive Dystonia/Infantile Parkinsonism Associated with Mutations at the Human Tyrosine Hydroxylase Locus -- 113. Dopamine Is a Pathogenetic Factor in HIV-Induced Neuro-AIDS -- 114. Models of Parkinsonโs Disease -- 115. The Effect of Acute Loading with Selegiline and Selegiline with Levodopa on Blood Pressure and Plasma Norepinephrine Levels in Chronic Parkinsonian Patients -- 116. Cardiac Sympathetic Imaging with Radiolabelled Metaiodobenzylguanidine (MIBG) in Patients with Parkinsonโs Disease -- 117. MIBG Scintigraphy in Parkinsonian Syndromes -- 118. Evaluation of Sympathetic Nerve Function in Patients with Heart Failure by MIBG Myocardial Scintigraphy -- 119. Familial Orthostatic Tachycardia due to Norepinephrine Transporter (SLC6A2) Deficiency -- 120. Sympathetic Innervation and Blood Flow in the Diabetec Heart -- 121. Dynamic Monitoring of Neurological Diseases by CSF Clinical Markers -- 122. Comparative Physiology and Morphology of Catecholamine Systems: Beta Adrenergic Receptor-Mediated Attenuation of TNF?-Stimulated ICAM-1 Expression on Human Brain Microvascular Endothelial Cells -- 123. Cloning of Novel Genes from the Human Spinal Cord by Molecular Profiling -- 124. Molecular Biology of Conformational Diseases -- 125. An Approach to Establish Antemortem Diagnosis of Dementia with Lewy Bodies -- 126. Sympathoadrenal Activity and Cardiovascular Responses during Space Flight -- 127. Estrogen Metabolism: Does the Formation of Estrogen Quinone Provide a Potential Pathway to Breast Carcinogenesis?